MX338036B - Expresion proteinica a partir de acidos nucleicos multiples. - Google Patents
Expresion proteinica a partir de acidos nucleicos multiples.Info
- Publication number
- MX338036B MX338036B MX2013003820A MX2013003820A MX338036B MX 338036 B MX338036 B MX 338036B MX 2013003820 A MX2013003820 A MX 2013003820A MX 2013003820 A MX2013003820 A MX 2013003820A MX 338036 B MX338036 B MX 338036B
- Authority
- MX
- Mexico
- Prior art keywords
- cho cell
- selection agent
- nucleic acid
- eukaryotic selection
- transfecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
Abstract
La presente invención se refiere a un método para la producción recombinante de una inmunoglobulina heteróloga secretada en una célula CHO que comprende las siguientes etapas: i) proporcionar una célula CHO la cual está adaptada para crecer en cultivo en suspensión, adaptada para crecer en medio libre de suero, libre de micoplasmas y libre de virus, ii) proporcionar un vector que comprende un origen de replicación procariótico, un primer ácido nucleico que confiere resistencia contra un agente de selección procariótico, un segundo ácido nucleico que codifica para la cadena pesada de la inmunoglobulina heteróloga, un tercer ácido nucleico que codifica para la cadena ligera de la inmunoglobulina heteróloga, un cuarto ácido nucleico que confiere resistencia contra un agente de selección eucariótico, iii) transfectar la célula CHO, en donde la transfección comprende a) transfectar la célula CHO con el vector que comprende un cuarto ácido nucleico que confiere resistencia contra un primer agente de selección eucariótico, b) seleccionar una célula CHO por crecimiento en medio de cultivo que contiene el primer agente de selección eucariótico, c) transfectar la célula CHO seleccionada con el vector que comprende un cuarto ácido nucleico que confiere resistencia contra un segundo agente de selección eucariótico diferente del primer agente de selección eucariótico, d) seleccionar una célula CHO mediante crecimiento selectivo en medio de cultivo que contiene el primero y segundo agentes de selección eucarióticos, iv) cultivar la célula CHO transfectada en un medio en presencia del primero y segundo agentes de selección eucarióticos bajo condiciones adecuadas para la expresión del segundo y tercer ácidos nucleicos, y v) recuperar la inmunoglobulina heteróloga secretada del medio de cultivo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07019999 | 2007-10-12 | ||
PCT/EP2008/008523 WO2009046978A1 (en) | 2007-10-12 | 2008-10-09 | Protein expression from multiple nucleic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
MX338036B true MX338036B (es) | 2016-03-31 |
Family
ID=39204855
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010003622A MX2010003622A (es) | 2007-10-12 | 2008-10-09 | Expresion proteinica a partir de acidos nucleicos multiples. |
MX2013003820A MX338036B (es) | 2007-10-12 | 2008-10-09 | Expresion proteinica a partir de acidos nucleicos multiples. |
MX2010003620A MX2010003620A (es) | 2007-10-12 | 2008-10-13 | Linea de celulas cho-k1. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010003622A MX2010003622A (es) | 2007-10-12 | 2008-10-09 | Expresion proteinica a partir de acidos nucleicos multiples. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010003620A MX2010003620A (es) | 2007-10-12 | 2008-10-13 | Linea de celulas cho-k1. |
Country Status (20)
Country | Link |
---|---|
US (5) | US8771988B2 (es) |
EP (4) | EP2592147A1 (es) |
JP (2) | JP5642549B2 (es) |
KR (2) | KR101280704B1 (es) |
CN (2) | CN101815786A (es) |
AU (2) | AU2008309934B2 (es) |
BR (2) | BRPI0818165B8 (es) |
CA (2) | CA2701646C (es) |
DK (1) | DK2592148T3 (es) |
ES (1) | ES2695999T3 (es) |
HR (1) | HRP20181833T1 (es) |
HU (1) | HUE039950T2 (es) |
IL (2) | IL203900A (es) |
LT (1) | LT2592148T (es) |
MX (3) | MX2010003622A (es) |
PL (1) | PL2592148T3 (es) |
PT (1) | PT2592148T (es) |
SI (1) | SI2592148T1 (es) |
TR (1) | TR201816045T4 (es) |
WO (2) | WO2009046978A1 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2441831B9 (en) * | 2009-06-11 | 2019-03-06 | Inter-University Research Institute Corporation Research Organization of Information and Systems | Process for production of protein |
EP2564695B1 (en) | 2009-07-08 | 2015-04-15 | Kymab Limited | Animal models and therapeutic molecules |
US20120204278A1 (en) * | 2009-07-08 | 2012-08-09 | Kymab Limited | Animal models and therapeutic molecules |
HUE048980T2 (hu) | 2009-08-11 | 2020-08-28 | Hoffmann La Roche | Fehérjék elõállítása glutaminmentes sejttenyésztõ táptalajban |
EP2524041A4 (en) * | 2009-11-16 | 2013-08-07 | Acyte Biotech Pty Ltd | RECOMBINANT ANTIBODY VECTOR |
US9096879B2 (en) * | 2009-11-24 | 2015-08-04 | Biogen Ma Inc. | Method of supplementing culture media to prevent undesirable amino acid substitutions |
CA2797140C (en) | 2010-04-26 | 2018-01-23 | Novartis Ag | Improved cell culture medium |
EP2616541B1 (en) * | 2010-09-15 | 2014-11-12 | MedImmune Limited | Chinese hamster ovary cell line |
AU2011325833C1 (en) | 2010-11-05 | 2017-07-13 | Zymeworks Bc Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
WO2013041844A2 (en) | 2011-09-19 | 2013-03-28 | Kymab Limited | Antibodies, variable domains & chains tailored for human use |
WO2013063702A1 (en) | 2011-11-04 | 2013-05-10 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the fc domain |
KR102280111B1 (ko) | 2011-12-22 | 2021-07-21 | 에프. 호프만-라 로슈 아게 | 발현 벡터 구성, 신규한 생산 세포 생성 방법 및 폴리펩티드의 재조합 생산을 위한 그의 용도 |
US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
EP2674495A1 (en) * | 2012-06-14 | 2013-12-18 | Sanofi | CHO expression system |
WO2014004586A1 (en) | 2012-06-25 | 2014-01-03 | Zymeworks Inc. | Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells |
US9914785B2 (en) | 2012-11-28 | 2018-03-13 | Zymeworks Inc. | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof |
WO2014145098A1 (en) | 2013-03-15 | 2014-09-18 | Genentech, Inc. | Cell culture compositions with antioxidants and methods for polypeptide production |
US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
US11707056B2 (en) | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
DE112014004537T5 (de) | 2013-10-01 | 2016-07-21 | Kymab Limited | Tiermodelle und therapeutische Moleküle |
MX2016006572A (es) | 2013-11-27 | 2016-12-09 | Zymeworks Inc | Construcciones de union a antigenos biespecificas dirigidas a her2. |
EP3122869B2 (en) | 2014-03-24 | 2022-08-10 | Biogen MA Inc. | Methods for overcoming glutamine deprivation during mammalian cell culture |
BR112016024462B1 (pt) * | 2014-05-06 | 2022-12-27 | Genentech, Inc | Métodos para a preparação de um anticorpo |
AU2015290571B2 (en) * | 2014-07-16 | 2021-03-04 | Heartseed Inc. | New undifferentiated stem cell removal and myocardial purification and refinement culture medium |
EP3289092B1 (en) * | 2015-04-27 | 2020-02-12 | Momenta Pharmaceuticals, Inc. | Method of manufacturing a therapeutic protein |
US11098310B2 (en) | 2016-01-27 | 2021-08-24 | Just-Evotec Biologics, Inc. | Expression from transposon-based vectors and uses |
US11261462B2 (en) | 2016-01-27 | 2022-03-01 | Just-Evotec Biologics, Inc. | Inducible expression from transposon-based vectors and uses |
JP6937309B2 (ja) | 2016-01-27 | 2021-09-22 | ジャスト−エヴォテック バイオロジックス、インコーポレイテッド | ハイブリッドプロモーターおよびその使用 |
US10202435B2 (en) | 2016-04-15 | 2019-02-12 | Alder Biopharmaceuticals, Inc. | Anti-PACAP antibodies and uses thereof |
EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
WO2017189964A2 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
GB201718088D0 (en) * | 2017-11-01 | 2017-12-13 | Autolus Ltd | Vectors |
CN111019881B (zh) * | 2019-11-21 | 2020-10-09 | 中山康天晟合生物技术有限公司 | 一种适应高渗透压、高铵离子、高乳酸生长环境的细胞 |
MX2022013173A (es) | 2020-04-24 | 2022-11-30 | Hoffmann La Roche | Modulacion de enzimas y vias con compuestos de sulfhidrilo y sus derivados. |
CN112920995A (zh) * | 2021-03-31 | 2021-06-08 | 赵峻岭 | 一种间充质干细胞培养血清加油包及其应用 |
CN115521919B (zh) * | 2022-11-04 | 2023-04-11 | 广州誉衡生物科技有限公司 | 一种调节pd-1抗体和lag-3抗体酸性电荷异构体的cho细胞培养方法 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4912038A (en) | 1984-12-11 | 1990-03-27 | California Biotechnology Inc. | Recombinant DNA sequence encoding alveolar surfactant protein |
EP0217822B1 (en) | 1985-02-13 | 1993-05-12 | Scios Nova Inc. | Human metallothionein-ii promoter in mammalian expression system |
US5550036A (en) | 1986-04-09 | 1996-08-27 | Eli Lilly And Company | Method for co-amplification of human protein C genes in human cells |
WO1989000605A1 (en) | 1987-07-16 | 1989-01-26 | Codon | Transfected cells containing plasmids having genes oriented in opposing directions and methods of obtaining the same |
CA1341235C (en) * | 1987-07-24 | 2001-05-22 | Randy R. Robinson | Modular assembly of antibody genes, antibodies prepared thereby and use |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
EP0319206A3 (en) | 1987-11-30 | 1990-04-18 | Berlex Laboratories, Inc. | Gene amplification |
WO1989010959A1 (en) | 1988-05-06 | 1989-11-16 | Codon | Supertransformants for high expression rates in eukaryotic cells |
DD287531A5 (de) | 1988-06-16 | 1991-02-28 | Akademie Der Wissenschaften,De | Verfahren zur herstellung von humanem wachstumshormon (sth) in tierischen zellen |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
US5464778A (en) | 1989-03-08 | 1995-11-07 | Board Of Regents Of The University Of Oklahoma | Glycoprotein ligand for P-selectin and methods of use thereof |
JP2859679B2 (ja) * | 1990-03-01 | 1999-02-17 | 協和醗酵工業株式会社 | 新規細胞株 |
GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
EP0557459B1 (en) | 1990-11-13 | 1997-10-22 | Immunex Corporation | Bifunctional selectable fusion genes |
GB9114468D0 (en) | 1991-07-04 | 1991-08-21 | Wellcome Found | Antibody production |
EP0569678A3 (en) | 1992-03-13 | 1994-10-26 | Yeda Res & Dev | Double transfectants of MHC genes as cellular vaccines for immunoprevention of tumor metastasis. |
US5420019A (en) | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
WO1994025067A1 (en) | 1993-05-04 | 1994-11-10 | Cytel Corporation | Antibodies to p-selectin and their uses |
EP0804590A1 (en) | 1993-05-21 | 1997-11-05 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
CA2169292C (en) | 1993-08-12 | 2010-11-23 | E. Edward Baetge | Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
WO1995017513A1 (en) * | 1993-12-23 | 1995-06-29 | Novo Nordisk A/S | Retransformation of filamentous fungi |
US5719050A (en) | 1993-12-24 | 1998-02-17 | Eiken Chemical Co., Ltd. | Animal cell culturing media containing N-acetyl-L-glutamic acid |
US5726041A (en) | 1995-08-30 | 1998-03-10 | Gentest Corporation | Method for detecting a receptor-ligand complex using a cytochrome P450 reporter gene |
EP1482031B1 (en) * | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
WO1998033523A1 (en) | 1997-01-31 | 1998-08-06 | Biovation Limited | Vaccination methods and molecules |
US5888809A (en) | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
EP1724282B1 (en) | 1997-05-21 | 2013-05-15 | Merck Patent GmbH | Method for the production of non-immunogenic proteins |
US6475725B1 (en) * | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
JP2002503444A (ja) | 1997-11-26 | 2002-02-05 | イーライ・リリー・アンド・カンパニー | リガンドファミリー遺伝子 |
IL138523A0 (en) | 1998-03-18 | 2001-10-31 | Pharmacopeia Inc | Eukaryotic cells stably expressing genes from multiple transfected episomes |
BR9905867A (pt) | 1998-11-06 | 2001-01-23 | Bio Sidus S A | Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula |
TW570977B (en) | 1998-12-07 | 2004-01-11 | Li-Wei Hsu | An expression system for producing recombinant human erythropoietin, method for purifying secreted human erythropoietin and uses thereof |
AU776910B2 (en) | 1998-12-08 | 2004-09-23 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Modifying protein immunogenicity |
DE19920712A1 (de) | 1999-05-05 | 2000-11-09 | Rhein Biotech Proz & Prod Gmbh | Verfahren zum Herstellen eines rekombinanten Proteines |
AU784506B2 (en) * | 1999-08-25 | 2006-04-13 | Immunex Corporation | Compositions and methods for improved cell culture |
AUPQ422399A0 (en) | 1999-11-24 | 1999-12-16 | University Of New South Wales, The | Method of screening transformed or transfected cells |
DE10036491A1 (de) | 2000-07-25 | 2002-02-07 | Roche Diagnostics Gmbh | Expression von Alkalischer Phosphatase in Hefe |
JP4723185B2 (ja) | 2001-11-28 | 2011-07-13 | サンド・アクチエンゲゼルシヤフト | 組換えポリペプチドの生産方法 |
AR038568A1 (es) | 2002-02-20 | 2005-01-19 | Hoffmann La Roche | Anticuerpos anti-a beta y su uso |
WO2003076588A2 (en) | 2002-03-05 | 2003-09-18 | Vitra Bioscience, Inc. | Multiplexed cell transfection using coded carriers |
DE10213201A1 (de) | 2002-03-25 | 2003-10-16 | Roche Diagnostics Gmbh | Erzeugung von schwach aktiven oder inaktiven Mutanten von Alkalischer Phosphatase und deren Expression in Hefe |
EP1460088A1 (en) * | 2003-03-21 | 2004-09-22 | Biotest AG | Humanized anti-CD4 antibody with immunosuppressive properties |
WO2004087758A2 (en) | 2003-03-26 | 2004-10-14 | Neopharm, Inc. | Il 13 receptor alpha 2 antibody and methods of use |
CA2885854C (en) | 2004-04-13 | 2017-02-21 | F. Hoffmann-La Roche Ag | Anti-p-selectin antibodies |
WO2005113770A1 (en) | 2004-05-13 | 2005-12-01 | Institut Gustave Roussy | Anti-rhoa and -rhoc sirnas and therapeutic compositions comprising them. |
TWI306862B (en) | 2005-01-03 | 2009-03-01 | Hoffmann La Roche | Antibodies against il-13 receptor alpha 1 and uses thereof |
DE102005046225B4 (de) * | 2005-09-28 | 2012-01-05 | Cellca Gmbh | Verbessertes Zellkulturmedium |
TW200722436A (en) | 2005-10-21 | 2007-06-16 | Hoffmann La Roche | A peptide-immunoglobulin-conjugate |
CA2645322A1 (en) | 2006-03-16 | 2007-09-27 | Genentech, Inc. | Methods of treating lupus using cd4 antibodies |
EP2177536B1 (en) * | 2006-03-30 | 2014-06-04 | Glaxo Group Limited | Antibodies against amyloid-beta peptide |
CL2008002092A1 (es) | 2007-07-20 | 2009-05-29 | Hoffmann La Roche | Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas. |
-
2008
- 2008-10-09 CN CN200880110216A patent/CN101815786A/zh active Pending
- 2008-10-09 ES ES12191535T patent/ES2695999T3/es active Active
- 2008-10-09 LT LTEP12191535.9T patent/LT2592148T/lt unknown
- 2008-10-09 DK DK12191535.9T patent/DK2592148T3/en active
- 2008-10-09 CA CA2701646A patent/CA2701646C/en active Active
- 2008-10-09 SI SI200832013T patent/SI2592148T1/sl unknown
- 2008-10-09 BR BRPI0818165A patent/BRPI0818165B8/pt active IP Right Grant
- 2008-10-09 TR TR2018/16045T patent/TR201816045T4/tr unknown
- 2008-10-09 JP JP2010527368A patent/JP5642549B2/ja active Active
- 2008-10-09 MX MX2010003622A patent/MX2010003622A/es active IP Right Grant
- 2008-10-09 EP EP12170648.5A patent/EP2592147A1/en not_active Withdrawn
- 2008-10-09 WO PCT/EP2008/008523 patent/WO2009046978A1/en active Application Filing
- 2008-10-09 US US12/681,781 patent/US8771988B2/en active Active
- 2008-10-09 AU AU2008309934A patent/AU2008309934B2/en active Active
- 2008-10-09 PL PL12191535T patent/PL2592148T3/pl unknown
- 2008-10-09 MX MX2013003820A patent/MX338036B/es unknown
- 2008-10-09 EP EP08836893A patent/EP2207881A1/en not_active Ceased
- 2008-10-09 EP EP12191535.9A patent/EP2592148B1/en active Active
- 2008-10-09 HU HUE12191535A patent/HUE039950T2/hu unknown
- 2008-10-09 KR KR1020107007780A patent/KR101280704B1/ko active IP Right Grant
- 2008-10-09 PT PT12191535T patent/PT2592148T/pt unknown
- 2008-10-13 CA CA2701677A patent/CA2701677A1/en not_active Abandoned
- 2008-10-13 WO PCT/EP2008/008636 patent/WO2009047007A1/en active Application Filing
- 2008-10-13 EP EP08836958A patent/EP2207882A1/en not_active Withdrawn
- 2008-10-13 JP JP2010528327A patent/JP2011500009A/ja active Pending
- 2008-10-13 KR KR1020107007756A patent/KR20100059967A/ko active Search and Examination
- 2008-10-13 US US12/681,783 patent/US20100221781A1/en not_active Abandoned
- 2008-10-13 MX MX2010003620A patent/MX2010003620A/es not_active Application Discontinuation
- 2008-10-13 CN CN200880111157A patent/CN101821394A/zh active Pending
- 2008-10-13 BR BRPI0818536-0A2A patent/BRPI0818536A2/pt not_active IP Right Cessation
- 2008-10-13 AU AU2008309881A patent/AU2008309881A1/en not_active Abandoned
-
2010
- 2010-02-11 IL IL203900A patent/IL203900A/en active IP Right Grant
- 2010-02-11 IL IL203902A patent/IL203902A0/en unknown
-
2014
- 2014-06-02 US US14/293,447 patent/US9428766B2/en active Active
-
2016
- 2016-07-27 US US15/221,481 patent/US20170166923A1/en not_active Abandoned
-
2018
- 2018-08-21 US US16/107,929 patent/US20190233842A1/en not_active Abandoned
- 2018-11-05 HR HRP20181833TT patent/HRP20181833T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010003622A (es) | Expresion proteinica a partir de acidos nucleicos multiples. | |
KR101812348B1 (ko) | 단백질의 생산 방법 | |
JP2016518833A5 (es) | ||
CN101687910B (zh) | 具有高效分泌信号序列的哺乳动物表达载体 | |
FI3536797T3 (fi) | Siirtogeenin tehostettu ilmentäminen ja prosessointi | |
DK1658365T3 (da) | Fremgangsmåde til genkloning af produktionsceller | |
JP2010536396A5 (es) | ||
US20180100006A1 (en) | Method for the expression of polypeptides using modified nucleic acids | |
HRP20130921T1 (hr) | Staniäśni klon koji proizvodi fsh | |
CN104884467A (zh) | 在遗传修饰的哺乳动物细胞中生产治疗性蛋白质 | |
JP2020509763A5 (es) | ||
Li et al. | Optimized gene synthesis and high expression of human interleukin-18 | |
WO2007015691A3 (en) | Methods and compositions for increasing longevity and protein yield from a cell culture | |
FI2875047T3 (fi) | Tuotantosolulinjan tehostajat | |
WO2016003368A1 (en) | Optimized vectors for the production of recombinant proteins | |
DE602004025011D1 (de) | Verfahren zur herstellung rekombinanter proteine | |
JP2012525826A (ja) | Cho/cert細胞系 | |
Suarez-Patino et al. | Transient expression of rabies virus glycoprotein (RVGP) in Drosophila melanogaster Schneider 2 (S2) cells | |
CN101300342A (zh) | 用于使哺乳动物细胞具备适应性的方法 | |
CN105622729B (zh) | 一种靶向编辑gs基因的多肽及其蛋白 | |
DE602004023408D1 (de) | Agments unter verwendung einer e.coli-signalsequenz sowie verfahren zur massenproduktion des antikörperfragments | |
KR20220003563A (ko) | 진핵 세포용 세포 배양 배지 | |
US10590426B2 (en) | Genetic control of cell size | |
CN104099354A (zh) | 重组ulp1激酶的编码序列、编码蛋白、含有该编码序列的质粒、及重组ulp1激酶的制备方法 | |
CN103233004B (zh) | 一种人工dna分子及检测目标基因表达的方法 |